Elisabeth Moyano

Associate professor

Universitat Pompeu Fabra
Country flagSpain

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

About

Elisabeth Moyano is an Associate Professor at Universitat Pompeu Fabra in Spain. Her research focuses on the biotechnological production of taxanes, particularly paclitaxel, through genetic approaches and in vitro culture enhancements. Recent publications include studies on the characterization of taxane hydroxylases and the recovery of paclitaxel from Taxus baccata vascular stem cells. She is also involved in teaching bioethical issues related to the COVID-19 pandemic.

Articles (10)

Year:

2024

Year:

2024

Year:

2023

Summary Paclitaxel is one of the most effective anticancer drugs ever developed. Although the most sustainable approach to its production is provided by plant cell cultures, the yield is limited by bottleneck enzymes in the taxane biosynthetic pathway: baccatin‐aminophenylpropanoyl‐13‐ O ‐transferase (BAPT) and 3′‐ N ‐debenzoyltaxol N ‐benzoyltransferase (DBTNBT). With the aim of enhancing paclitaxel production by overcoming this bottleneck, we obtained distinct lines of Taxus baccata in vitro roots, each independently overexpressing either of the two flux‐limiting genes, BAPT or DBTNBT, through a Rhizobium rhizogenes A4‐mediated transformation. Due to the slow growth rate of the transgenic Taxus roots, they were dedifferentiated to obtain callus lines and establish cell suspensions. The transgenic cells were cultured in a two‐stage system and stimulated for taxane production by a dual elicitation treatment with 1 μ m coronatine plus 50 m m of randomly methylated‐β‐cyclodextrins. A high overexpression of BAPT (59.72‐fold higher at 48 h) and DBTNBT (61.93‐fold higher at 72 h) genes was observed in the transgenic cell cultures, as well as an improved taxane production. Compared to the wild type line (71.01 mg/L), the DBTNBT line produced more than four times higher amounts of paclitaxel (310 mg/L), while the content of this taxane was almost doubled in the BAPT line (135 mg/L). A transcriptional profiling of taxane biosynthetic genes revealed that GGPPS , TXS and DBAT genes were the most reactive to DBTNBT overexpression and the dual elicitation, their expression increasing gradually and constantly. The same genes exhibited a pattern of isolated peaks of expression in the elicited BAPT ‐overexpressing line.

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (3)

Irene Cambra Badii

PDI - professor

Universitat de Vic - Universitat Central de Catalunya

SPAIN
View details

Diego Hidalgo-Martinez

Lecturer / Serra Hunter Fellow

University of Barcelona

SPAIN
View details

Mercedes Bonfill

-

SPAIN
View details